<DOC>
	<DOCNO>NCT01874964</DOCNO>
	<brief_summary>Methadone maintenance treatment ( MMT ) show effective reduce drug use , criminal activity recidivism . Given effectiveness , maintain individual enrol community MMT commit Department Corrections short term incarceration would improve post release outcome . However , rarely practice United States . Current practice Rhode Island Department Corrections detox inmates methadone within 30 day incarcerate . More 75 % individual incarcerate less six month . The period immediately release incarceration particularly high-risk time HIV problem include drug relapse overdose . The investigator hypothesize inmate incarcerate 6 month less well outcomes cost state less money maintain methadone dose relinked community clinic release , current practice detoxification .</brief_summary>
	<brief_title>Trial Methadone Maintenance Versus Methadone Detox Jail</brief_title>
	<detailed_description>The purpose study compare effectiveness maintain methadone treatment short-term incarceration vs. methadone detoxification continue treatment post release , relapse , reduce HIV risk behavior reincarceration . Persons inject opiate increase risk HIV injection sexual practice . A substantial proportion opiate addict person incarcerate majority nearly 8 million individual release correctional set year history addiction . The period immediately release incarceration particularly high-risk time HIV problem include drug relapse overdose . Methadone widely use opiate replacement therapy United States . Despite demonstrated benefit decrease drug use , criminal activity , recidivism , individual methadone treatment reincarcerated year . More 75 % individual incarcerate less six month . A program maintain individual therapeutic dose increase likelihood successfully return treatment upon release . The following primary specific aim drive research : 1 . To determine effect maintain methadone treatment short-term incarceration vs. methadone detoxification time-to-post-release methadone treatment re-entry relapse . 2 . To determine whether maintain methadone treatment short-term incarceration effective reduce HIV risk behavior ( inject sexual ) methadone detoxification upon community re-entry . 3 . To determine whether maintain methadone treatment short-term incarceration effective reduce reincarceration methadone detoxification . 4 . To determine impact cost first three specific aim . Secondary aim include determine effect methadone maintenance short-term incarceration versus methadone detoxification : - retention community base methadone treatment ; - number fatal nonfatal overdoses ; - criminal behavior The targeted population 300 recently incarcerate inmate enrol community methadone treatment time incarceration . Follow-up interview occur 1-month post release incarceration 6 , 12 month baseline independent study site . Both group receive risk behavior reduction counsel intervention linkage community methadone treatment upon release . If project able demonstrate maintain inmate methadone short-term incarceration effective , influence correctional policy work collaboratively community substance use treatment provider minimize disruption treatment .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>currently incarcerate RI Department Corrections enrol Rhode Island methadone treatment program time incarceration currently maintain preincarceration methadone dosage level estimate total incarceration time &lt; 6 month &gt; 1 week willing randomized conduct followup interview 12 month English Spanishspeaking able give inform consent age 18 year old willing remain MMT continue MMT release . pregnancy ( pregnant woman maintain preincarceration level methadone throughout pregnancy health health fetus RI DOC , NOT eligible randomize Arm 2 ) fulfil inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>HIV Prevention</keyword>
	<keyword>Opioid-Related Disorders</keyword>
	<keyword>Medication Assisted Treatment</keyword>
	<keyword>Methadone</keyword>
</DOC>